Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron degeneration resulting in paralysis and death, usually within 3 years of onset. Pathological and animal studies implicate neurofilament involvement in ALS, but whether this is primary or secondary is not clear. The heavy neurofilament subunit (NFH) tail is composed of a repeating amino acid motif, usually X-lysine-serine-proline-Y-lysine (XKSPYK), where X is a single amino acid and Y is one to three amino acids. There are two common polymorphic variants of 44 or 45 repeats. The tail probably regulates axonal calibre, with interfilament spacing determined by phosphorylation of the KSP motifs. A previous study suggested an association between sporadic cases of ALS and NFH tail deletions, but two subsequent studies have found none. We have analysed samples from two different populations (UK 207, Scandinavia 323) with age-matched controls for each group (UK 219, Scandinavia 228) and have found four novel NFH tail deletions, each involving a whole motif. These were found in three patients with sporadic ALS and a family with autosomal dominant ALS, although another was also found in two young controls. In all cases motif deletions were only associated with disease when paired with the long NFH allele. The deletions all occurred within a small region of the NFH tail. This has allowed us to propose a structural organization of the tail as well as allowing observed deletions both from this study and previous reports to be organized into logical groups. These results strongly suggest that NFH motif deletions can be a primary event in ALS but that they are not common.

[1]  Veeranna,et al.  Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. , 1998, Biochemistry.

[2]  J. Powell,et al.  Familial amyotrophic lateral sclerosis , 1997, Neurology.

[3]  A. Al-Chalabi,et al.  Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: Analysis of 155 cases and identification of novel insertion mutation , 1997, Annals of neurology.

[4]  P. Andersen,et al.  Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. , 1997, Brain : a journal of neurology.

[5]  M. Gurney,et al.  Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[6]  H. Horvitz,et al.  Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis , 1997, Annals of neurology.

[7]  A. Smit,et al.  The origin of interspersed repeats in the human genome. , 1996, Current opinion in genetics & development.

[8]  L. Bruijn,et al.  Sequence variants in human neurofilament proteins: Absence of linkage to familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[9]  R. Liem,et al.  Phosphorylation of the High Molecular Weight Neurofilament Protein (NF-H) by Cdk5 and p35* , 1996, The Journal of Biological Chemistry.

[10]  R. Starr,et al.  A cdc2-like kinase distinct from cdk5 is associated with neurofilaments. , 1996, Journal of cell science.

[11]  P. Steinert Intermediate filaments in health and disease , 1996, Experimental & Molecular Medicine.

[12]  G. Rouleau,et al.  Analysis of the KSP repeat of the neurofilament heavy subunit in familial amyotrophic lateral sclerosis , 1996, Neurology.

[13]  Jerzy Jurka,et al.  Censor - a Program for Identification and Elimination of Repetitive Elements From DNA Sequences , 1996, Comput. Chem..

[14]  M. Gurney,et al.  Benefit of vitamin E, riluzole, and gababapentin in a transgenic model of familial amyotrophic lateral sclerosis , 1996, Annals of neurology.

[15]  Guy A. Rouleau,et al.  SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .

[16]  A. Clark,et al.  SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. , 1996, Annals of neurology.

[17]  S. Brady Mice overexpressing the human neurofilament heavy gene as a model of ALS , 1995, Neurobiology of Aging.

[18]  R. Swingler,et al.  Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. , 1995, Journal of medical genetics.

[19]  Lorene M. Nelson,et al.  Epidemiology of ALS. , 1995, Clinical neuroscience.

[20]  V. Meininger,et al.  Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. , 1994, Human molecular genetics.

[21]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[22]  G. Rouleau,et al.  Polymorphism in the multi-phosphorylation domain of the human neurofilament heavy-subunit-encoding gene. , 1993, Gene.

[23]  L. Cork,et al.  Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease , 1993, Cell.

[24]  O. Ohara,et al.  Neurofilament deficiency in quail caused by nonsense mutation in neurofilament-L gene , 1993, The Journal of cell biology.

[25]  R. Nixon,et al.  The Regulation of Neurofilament Protein Dynamics by Phosphorylation: Clues to Neurofibrillary Pathobiology , 1993, Brain pathology.

[26]  D. Soppet,et al.  Evidence for unequal crossing over in the evolution of the neurofilament polypeptide H. , 1992, The Journal of biological chemistry.

[27]  T. Gotow,et al.  Macromolecular structure of reassembled neurofilaments as revealed by the quick-freeze deep-etch mica method: difference between NF-M and NF-H subunits in their ability to form cross-bridges. , 1992, European journal of cell biology.

[28]  T. Nunoya,et al.  The hypotrophic axonopathy mutant in Japanese quail. , 1992, The Journal of heredity.

[29]  Ralph A. Nixon,et al.  Slow axonal transport , 1992, Current Biology.

[30]  R. Nixon,et al.  Neurofilament phosphorylation: a new look at regulation and function , 1991, Trends in Neurosciences.

[31]  M. Landon,et al.  Inclusion bodies in motor cortex and brainstem of patients with motor neurone disease are detected by immunocytochemical localisation of ubiquitin , 1989, Neuroscience Letters.

[32]  M. Swash,et al.  Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study. , 1989, Brain : a journal of neurology.

[33]  N. Spinner,et al.  Cloning of a cDNA encoding the rat high molecular weight neurofilament peptide (NF-H): developmental and tissue expression in the rat, and mapping of its human homologue to chromosomes 1 and 22. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. Mayer,et al.  A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin , 1988, Neuroscience Letters.

[35]  M. Swash,et al.  Ubiquitin deposits in anterior horn cells in motor neurone disease , 1988, Neuroscience Letters.

[36]  N. Hirokawa,et al.  MAP2 is a component of crossbridges between microtubules and neurofilaments in the neuronal cytoskeleton: quick-freeze, deep-etch immunoelectron microscopy and reconstitution studies , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  R. Lazzarini,et al.  The structure and organization of the human heavy neurofilament subunit (NF‐H) and the gene encoding it. , 1988, The EMBO journal.

[38]  D. Wion,et al.  Isolation of a cDNA for the rat heavy neurofilament polypeptide (NF‐H) , 1986, FEBS letters.

[39]  S. Carpenter,et al.  Neurofibrillary axonal swellings and amyotrophic lateral sclerosis , 1984, Journal of the Neurological Sciences.

[40]  Jm Charcot,et al.  Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere , 1869 .